Form D · Pharmaceuticals

FIRST CHINA PHARMACEUTICAL GROUP, INC.

Kunming City, Yunnan Province, F4 · CIK 0001432254

Offering snapshot reported Apr 12, 2011 · SEC filing

Reported sold
$3.83M
Offering amount: $7.56M
Investors reported
24
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Mar 18, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.91M$3.83MMar 29, 2011: $2,938,000.00Mar 29, 2011Apr 12, 2011: $3,829,000.00Apr 12, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,938,000 → $3,829,000
  • Reported investors12 → 24

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 12, 2011Amendment$3,829,000$891,000vs Mar 29, 201124SEC filing
Mar 29, 2011Initial$2,938,000No comparison12SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$560K (estimated)
Finders' fees
$0
Form D file number
021-157516
Issuer is offering of up to 280 units, each consisting of 27,778 shares of common stock at $89.99 and an equal number of A-1 Warrants and A-2 Warrants, and stock underlying such warrants. Includes value of shares and warrants described in Item 15 below.
Represents 8% of total offering amount. Placement Agent may also receive shares & warrants up to 8% of the total shares & warrants included in the units, which shares, warrants & underlying stock are included in this Form D.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Sandgrain Securities, Inc.26004
Middlebury Securities, LLC122602

Source: Form D, filed Apr 12, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Yong Kang Chen Executive
Jing Gong Executive
Gregory D. Tse Director, Executive
Zhen Jiang Wang Director, Executive
Jia Li Yi Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
Number 504, West Ren Min Road
Kunming City, Yunnan Province, F4, 650000